Lisata Therapeutics Inc.

NASDAQ: LSTA · Real-Time Price · USD
2.52
-0.04 (-1.56%)
At close: Aug 15, 2025, 3:59 PM
2.53
0.40%
After-hours: Aug 15, 2025, 04:00 PM EDT

Lisata Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
1.07M 1M 1M n/a n/a n/a n/a 121.37M 121.37M 121.37M 121.37M n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
128K 129K 132K 179K 185K 188K 190K 190K 151K 110K 69K 30K 36K 46K 55K 47K 33K 16K
Gross Profit
942K 871K 868K -179K -185K -188K -190K 121.18M 121.22M 121.26M 121.3M -30K -36K -46K -55K -47K -33K -16K
Operating Income
-21M -21.66M -22.41M -23.48M -24.11M -25.46M -25.71M -26.22M -27.59M -27.43M -27.21M -27.52M -27.16M -27.58M -29.05M -27.65M -26.03M -23.17M
Interest Income
1.28M 1.56M 1.88M 2.2M 2.47M 2.64M 2.05M 1.94M 1.22M 556K 556K n/a n/a n/a n/a n/a n/a n/a
Pretax Income
-19.89M -20.27M -20.78M -21.54M -21.87M -23.18M -23.17M -23.8M -55.92M -56.19M -56.7M -57.51M -27.05M -27.62M -28.97M -27.61M -26.01M -23.09M
Net Income
-18.92M -19.31M -19.98M -20.74M -21.07M -20.05M -20.84M -21.46M -53.59M -56M -54.04M -54.84M -24.39M -23.63M -27.47M -26.1M -24.5M -12.22M
Selling & General & Admin
11.72M 11.96M 12.03M 12.04M 11.83M 12.62M 12.97M 13.33M 14.7M 14.46M 14.14M 13.47M 12.37M 11.7M 11.37M 11.21M 10.69M 10.34M
Research & Development
10.35M 10.7M 11.33M 11.4M 12.23M 12.8M 12.73M 12.89M 43.28M 43.36M 43.46M 44.44M 14.79M 15.88M 17.68M 16.44M 15.34M 12.83M
Other Expenses
n/a n/a n/a n/a n/a n/a -13K -19K -19K -19K -6K 15K 15K 15K 15K n/a n/a n/a
Operating Expenses
22.07M 22.66M 23.36M 23.44M 24.07M 25.42M 25.71M 26.22M 57.98M 57.82M 57.6M 57.91M 27.16M 27.58M 29.05M 27.65M 26.03M 23.17M
Interest Expense
n/a n/a n/a n/a n/a n/a n/a 1.37M 1.37M 1.37M 1.4M 22K 22K 22K n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a -46K -46K -46K -46K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
22.07M 22.66M 23.41M 23.48M 24.11M 25.46M 25.71M 26.22M 57.98M 57.82M 57.6M 57.91M 27.16M 27.58M 29.05M 27.65M 26.03M 23.17M
Income Tax Expense
-962K -962K -798K -798K -798K -3.13M -2.33M -2.33M -3M -862K -3.34M -3.38M -2.71M -4.03M -1.59M -1.57M -1.62M -10.98M
Shares Outstanding (Basic)
8.61M 8.6M 8.33M 8.32M 8.31M 8.29M 8.14M 8.14M 8.02M 7.99M 4.96M 4.75M 4.04M 4.04M 3.98M 3.97M 3.97M 2.81M
Shares Outstanding (Diluted)
8.61M 8.6M 8.33M 8.32M 8.31M 8.29M 8.14M 8.14M 8.02M 7.99M 4.96M 4.75M 4.04M 4.04M 3.98M 3.97M 3.97M 2.81M
EPS (Basic)
-2.23 -2.3 -2.4 -2.51 -2.57 -2.46 -2.58 -3.13 -10.36 -11.46 -11.74 -12.23 -6.09 -5.92 -7.74 -8.87 -11.43 -2.5
EPS (Diluted)
-2.23 -2.3 -2.4 -2.51 -2.57 -2.46 -2.58 -3.13 -10.36 -11.46 -11.74 -12.23 -6.09 -5.92 -7.74 -8.87 -11.43 -2.5
EBITDA
-20.12M -20.98M -21.9M -23.3M -23.93M -25.28M -25.52M -26.03M -57.49M -57.38M -57.19M -57.54M -27.12M -27.54M -29M -27.58M -25.96M -23.11M
EBIT
-20.63M -21.49M -22.41M -23.48M -24.11M -25.46M -25.71M -26.22M -57.64M -57.49M -57.26M -57.57M -27.16M -27.58M -29.05M -27.65M -26.03M -23.17M
Depreciation & Amortization
170K 171K 174K 180K 185K 187K 189K 189K 150K 110K 69K 30K 36K 46K 55K 64K 66K 64K